Page 13 - Air Force Material Command News Today

JOINT BASE SAN ANTONIO-LACKLAND, Texas – Members of the Defense Department can view a live stream of the 2021 Installation and Mission Support Weapons and Tactics Conference outbriefs held April 21 at Joint Base San Antonio-Lackland. The virtual presentation takes place from 8 a.m. to noon (CDT) and can be accessed with a valid DOD Common Access Card at MAWG Outbrief Live Stream. Hosted by the Air Force Installation and Mission Support Center, the annual conference is the Air Force’s premie...

CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference News provided by Share this article MONMOUTH JUNCTION, N.J., March 12, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Oppenheimer 31 st Annual Healthcare Conference. Chief Executi...

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb® Media Links Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, GERMANY and MONMOUTH JUNCTION, N.J., March 2, 2021 – B. Braun Avitum AG, a leading manufacturer of medical devices a...

CET- Comunicado - ";ultimaHoraHtml += " " + json.lead + "";}ultimaHoraHtml += ""; document.getElementById("urgente").innerHTML = ultimaHoraHtml; } } }); The CytoSorb adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream./ - CYTOSORBENTS B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI* Continuous Blood Purification Platform wit...

CytoSorbents to Present at the Cowen 41st Annual Health Care Conference News provided by Share this article MONMOUTH JUNCTION, N.J., Feb. 24, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Cowen 41 st Annual Health Care Conference. Chief Executive Officer,...

A new space art exhibit hosted by the National Museum of the U.S. Air Force in conjunction with the International Association of Astronomical Artists (IAAA) titled “The Beauty of Space,” will open at the museum on Feb. 26, 2021. The Exhibit, which will be,

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to...

National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery News provided by Share this article MONMOUTH JUNCTION, N.J., Feb. 4, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, highlights the ...

The two planes will need to be tested and flown before more are built. The U.S. Air Force (USAF) is moving rapidly along with the construction of its first two B-21 Raiders, as the next-generation stealth bomber inches ever closer to full-scale serial production. According to senior Air Force officials, the first B-21 Raider will be completed in early 2022 and undertake its maiden flight later that year. The USAF initially stated that the maiden flight would occur by December 2021, but Randall ...

Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 21, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces the immediate appointment of David D. Cox, Ph.D., M.B.A., as Vice President – Global Regulatory Affairs. Dr. Cox was most recently Vice President of Regulator...